New Legal and Compliance Director
SFEE Announcement
News
Miscellaneous
SFEE–MoH meeting on Pharmaceutical Policy
Key points of the meeting
How do companies that have struck MFN deals see Europe?
The CEOs of three companies have sounded warnings to the region
National Framework for Plasma-Derived Therapies
SFEE | October 2025
Greek Innovation Fund an important step, but a limited one, says industry
Statement by Michael Himonas, SFEE General Manager, on the Innovation Fund / Transitional Reimbursement Scheme – EURACTIV
Mrs. Ioanna Kontomanolopoulou appointed as Director General of HMVO
HMVO Press Release
